Risk factors for developing ESBL E. coli: Can clinicians predict infection in patients with prior colonization?

Journal of Hospital Infection

Volumn 84, Issue 4, 2013, Pages 294-299

  Goulenok, T ^a   Ferroni, A ^a   Bille, E ^a,b   Lecuyer H ^a,b   Join Lambert, O ^a,b   Descamps, P ^a,b   Nassif, X ^a,b   Zahar, J R ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Colonization; Extended spectrum lactamase producing Escherichia coli; Infection

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEFOXITIN; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; GLYCOPEPTIDE; MACROLIDE; METRONIDAZOLE; QUINOLONE DERIVATIVE; RIFAMPICIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL COLONIZATION; BLADDER CATHETERIZATION; CHILD; COMORBIDITY; CONTROLLED STUDY; DIALYSIS; ENDOSCOPY; ENTERIC FEEDING; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY TRANSPLANTATION; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; PARENTERAL NUTRITION; PREDICTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; URINARY TRACT INFECTION;

COLONIZATION; EXTENDED-SPECTRUM Β-LACTAMASE-PRODUCING ESCHERICHIA COLI; INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CASE-CONTROL STUDIES; CATHETERIZATION; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG UTILIZATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PARIS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84880589014     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2013.04.018     Document Type: Article

References (18)

1. Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
2. Weinstein M.P., Towns M.L., Quartey S.M., et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997, 24:584-602.
3. Ben-Ami R., Schwaber M.J., Navon-Venezia S., et al. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis 2006, 42:925-934.
4. Pena C., Pujol M., Ricart A., et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. JHosp Infect 1997, 35:9-16.
5. Rodriguez-Bano J., Picon E., Gijon P., et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. JClin Microbiol 2010, 48:1726-1731.
6. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
7. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. Anew method of classifying prognostic comorbidity in longitudinal studies: development and validation. JChronic Dis 1987, 40:373-383.
8. Talbot G.H., Bradley J., Edwards J.E., Gilbert D., Scheld M., Bartlett J.G. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006, 42:657-668.
9. Sullivan A., Edlund C., Nord C.E. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001, 1:101-114.
10. Jernberg C., Lofmark S., Edlund C., Jansson J.K. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010, 156:3216-3223.
11. Donskey C.J. Antibiotic regimens and intestinal colonization with antibiotic-resistant Gram-negative bacilli. Clin Infect Dis 2006, 43(Suppl. 2):S62-S69.
12. Lee J., Pai H., Kim Y.K., et al. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. JAntimicrob Chemother 2007, 60:629-637.
13. Kaier K., Frank U., Hagist C., Conrad A., Meyer E. The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum beta-lactamase-producing strains: a time-series analysis. JAntimicrob Chemother 2009, 63:609-614.
14. Wiener J., Quinn J.P., Bradford P.A., et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999, 281:517-523.
15. Asensio A., Oliver A., Gonzalez-Diego P., et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000, 30:55-60.
16. Wener K.M., Schechner V., Gold H.S., Wright S.B., Carmeli Y. Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients. Antimicrob Agents Chemother 2010, 54:2010-2016.
17. Kaye K.S., Harris A.D., Gold H., Carmeli Y. Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients. Antimicrob Agents Chemother 2000, 44:1004-1009.
18. Lucet J.C., Chevret S., Decre D., et al. Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996, 22:430-436.